Patent Assignment
Reel/Frame 060969/0480
Assignment of Assignor's Interest
Recorded: 2022-09-01
Pages: 4
Assignors
RASCON, LUCAS
Executed: 2019-08-27
SANABRIA, ANGELICA
Executed: 2019-09-03
TIMMER, JOHN C.
Executed: 2019-08-26
ECKELMAN, BRENDAN P.
Executed: 2016-08-26
Assignee
INHIBRX, INC.
11025 N. TORREY PINES ROAD, SUITE 200, LA JOLLA, CALIFORNIA, 92037
Covered Property
(1)
Cll-1 Targeted Immunotherapies
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Intellectual Property Security Agreement
Feb 28, 2022
From: INHIBRX, INC.
To: OXFORD FINANCE LLC
Reel/Frame 059262/0780 →
Assignment of Assignor's Interest
Mar 7, 2022
From: JARJOUR, JORDAN; POGSON, MARK; LEUNG, WAI-HANG
To: 2SEVENTY BIO, INC.
Reel/Frame 059181/0824 →
Assignment of Assignor's Interest
Apr 22, 2024
From: 2SEVENTY BIO, INC.
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 067184/0175 →
Release of Security Interest
Jun 3, 2024
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: INHIBRX, INC.
Reel/Frame 067606/0247 →
Assignment of Assignor's Interest
Jun 10, 2024
From: INHIBRX, INC.
To: INHIBRX BIOSCIENCES, INC.
Reel/Frame 067679/0338 →
Security Interest
Jan 14, 2025
From: INHIBRX BIOSCIENCES, INC.
To: OXFORD FINANCE LLC; OXFORD FINANCE LLC
Reel/Frame 069894/0045 →